| abstract |
The present invention relates to the use of a compound of formula (I), wherein R1 is pyridyl or thiazolyl, any of which may optionally be substituted with C1-8alkyl or C2-8alkenyl; and a) R2 is methoxy and n is zero or one; or b) R2 is chlorine and n is zero; and pharmaceutically acceptable salts thereof for the prevention of blood vessel graft failure in patients undergoing artery bypass graft surgery. |